Literature DB >> 11326310

Isolation of a novel human gene, MARKL1, homologous to MARK3 and its involvement in hepatocellular carcinogenesis.

T Kato1, S Satoh, H Okabe, O Kitahara, K Ono, C Kihara, T Tanaka, T Tsunoda, Y Yamaoka, Y Nakamura, Y Furukawa.   

Abstract

Activation of the Wnt-signaling pathway is known to play a crucial role in carcinogenesis of various human organs including the colon, liver, prostate, and endometrium. To investigate the mechanisms underlying hepatocellular carcinogenesis, we attempted to identify genes regulated by beta-catenin/Tcf complex in a human hepatoma cell line, HepG2, in which an activated form of beta-catenin is expressed. By means of cDNA microarray, we isolated a novel human gene, termed MARKL1 (MAP/microtubule affinity-regulating kinase-like 1), whose expression was downregulated in response to decreased Tcf/LEF1 activity. The transcript expressed in liver consisted of 3529 nucleotides that contained an open reading frame of 2256 nucleotides, encoding 752 amino acids homologous to human MARK3 (MAP/microtubule affinity-regulating kinase 3). Expression levels of MARKL1 were markedly elevated in eight of nine HCCs in which nuclear accumulation of beta-catenin were observed, which may suggest that MARKL1 plays some role in hepatocellular carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326310      PMCID: PMC1505019          DOI: 10.1038/sj.neo.7900132

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  22 in total

1.  Systematic variation in gene expression patterns in human cancer cell lines.

Authors:  D T Ross; U Scherf; M B Eisen; C M Perou; C Rees; P Spellman; V Iyer; S S Jeffrey; M Van de Rijn; M Waltham; A Pergamenschikov; J C Lee; D Lashkari; D Shalon; T G Myers; J N Weinstein; D Botstein; P O Brown
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

2.  Exploring the metabolic and genetic control of gene expression on a genomic scale.

Authors:  J L DeRisi; V R Iyer; P O Brown
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

Review 3.  The adenomatous polyposis coli (APC) tumor suppressor.

Authors:  P Polakis
Journal:  Biochim Biophys Acta       Date:  1997-06-07

4.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

5.  beta-catenin is a target for the ubiquitin-proteasome pathway.

Authors:  H Aberle; A Bauer; J Stappert; A Kispert; R Kemler
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

6.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

7.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

8.  The APC tumour suppressor has a nuclear export function.

Authors:  R Rosin-Arbesfeld; F Townsley; M Bienz
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

9.  Sporadic medulloblastomas contain oncogenic beta-catenin mutations.

Authors:  R H Zurawel; S A Chiappa; C Allen; C Raffel
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

10.  Isolation and characterization of human NBL4, a gene involved in the beta-catenin/tcf signaling pathway.

Authors:  H Ishiguro; Y Furukawa; Y Daigo; Y Miyoshi; Y Nagasawa; T Nishiwaki; T Kawasoe; M Fujita; S Satoh; N Miwa; Y Fujii; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  2000-06
View more
  25 in total

Review 1.  Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Authors:  Narendran Annadurai; Khushboo Agrawal; Petr Džubák; Marián Hajdúch; Viswanath Das
Journal:  Cell Mol Life Sci       Date:  2017-06-20       Impact factor: 9.261

2.  Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.

Authors:  Roland Hubaux; Kelsie L Thu; Emily A Vucic; Larissa A Pikor; Sonia H Y Kung; Victor D Martinez; Mitra Mosslemi; Daiana D Becker-Santos; Adi F Gazdar; Stephen Lam; Wan L Lam
Journal:  Int J Cancer       Date:  2015-05-06       Impact factor: 7.396

3.  Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo.

Authors:  Jonathan B Hurov; Mei Huang; Lynn S White; Jochen Lennerz; Cheol Soo Choi; You-Ree Cho; Hyo-Jeong Kim; Julie L Prior; David Piwnica-Worms; Lewis C Cantley; Jason K Kim; Gerald I Shulman; Helen Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

4.  Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.

Authors:  Guoxiang Shen; Changjiang Xu; Rong Hu; Mohit R Jain; Sujit Nair; Wen Lin; Chung S Yang; Jefferson Y Chan; A-N Tony Kong
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

5.  ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5.

Authors:  Hui-Lung Sun; Ri Cui; JianKang Zhou; Kun-Yu Teng; Yung-Hsuan Hsiao; Kotaro Nakanishi; Matteo Fassan; Zhenghua Luo; Guqin Shi; Esmerina Tili; Huban Kutay; Francesca Lovat; Caterina Vicentini; Han-Li Huang; Shih-Wei Wang; Taewan Kim; Nicola Zanesi; Young-Jun Jeon; Tae Jin Lee; Jih-Hwa Guh; Mien-Chie Hung; Kalpana Ghoshal; Che-Ming Teng; Yong Peng; Carlo M Croce
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

6.  Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

Authors:  Jochen K Lennerz; Jonathan B Hurov; Lynn S White; Katherine T Lewandowski; Julie L Prior; G James Planer; Robert W Gereau; David Piwnica-Worms; Robert E Schmidt; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

7.  Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity.

Authors:  Chao Sun; Liang Tian; Jia Nie; Hai Zhang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

8.  Phosphorylation of the E3 ubiquitin ligase RNF41 by the kinase Par-1b is required for epithelial cell polarity.

Authors:  Katherine T Lewandowski; Helen Piwnica-Worms
Journal:  J Cell Sci       Date:  2013-11-20       Impact factor: 5.285

9.  Gene expression profiles of colonic mucosa in healthy young adult and senior dogs.

Authors:  Dong Yong Kil; Brittany M Vester Boler; Carolyn J Apanavicius; Lawrence B Schook; Kelly S Swanson
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

Review 10.  Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.

Authors:  Yutaka Midorikawa; Masatoshi Makuuchi; Wei Tang; Hiroyuki Aburatani
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.